Borna Disease Virus Proteins in Patients with CFS

References

• Holmes GP, Kaplan JE, Gantz NM, et al: Chronic Fatigue Syndrome: a work-ing case definition. Ann Intern Med 1988; 108: 387–9.
   PubMed Web of Science ®Google Scholar
• Fukuda K, Straus SE, Hickie I, et al: The Chronic Fatigue Syndrome: a com-prehensive approach to its definition an study. Ann Intern Med 1994; 121: 953–9.
   PubMed Web of Science ®Google Scholar
• Jones JF. Chronic Epstein Barr Virus Syndrome: Bull NY Acad Med 1988; 64: 538–43.
   PubMedGoogle Scholar
• Straus SF, Tosato GE, Armstrong G et al: Persisting illness and fatigue in adults with evidence of Epstein Barr Virus infection. Ann Intern Med 1985; 102: 7–16.
   PubMed Web of Science ®Google Scholar
• Spink WW. What is chronic brucellosis: Ann Intern Med 1951; 35: 358–74.
   PubMed Web of Science ®Google Scholar
• Sigardsson B, Sigarjonsson J, Sigurdsson HJ et al: A disease epidemic in Ice-land simulating poliomyelitis. Am J Hyg 1950; 52: 222–38.
   PubMedGoogle Scholar
• Buchwald D, Cheney PR, Peterson DL, et al: A chronic illness characterized by fatigue, neurologic and immunologic disorders an active human herpes virus type 6 infection. Ann Intern Med 1992; 116: 103–13.
   PubMed Web of Science ®Google Scholar
• Krueger GRF, Koch B, Ablashi DV: Persistent fatigue and depression in pa-tients with antibody to Human B Lymphotrophic Virus (letter). Lancet 1987; 2:36.
   PubMed Web of Science ®Google Scholar
• Gunn W, Komaroff A, Levine S, Connell D et al: Multilab retrovirus test re-sults for CFS patients from 3 distinct geographical areas. MMWR 1997; 1 pp.
   Google Scholar
• DeFreitas E, Hilliand B, Cheney P, Bell D et al: Retroviral sequences related to human T-Iymphotropic virus type II in patients with chronic fatigue immune dys-function syndrome. Proc Natl Acad Sci 88, April 1991: 2922–26.
   PubMed Web of Science ®Google Scholar
• Caliguri M, Murray C, Buchwald D et al: Phenotypic and functional deficien-cy of natural killer cells in patients with chronic fatigue syndrome. J Immunol 1987; 139: 3306–3313.
   PubMed Web of Science ®Google Scholar
• Klimas NG, Salvato FR, Morgan R, Fletcher M: Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol 1990; 28: 1403–10.
   PubMed Web of Science ®Google Scholar
• Suhadolnick RJ et al: Biochemical evidence for a novel low molecular weight 2-5 A dependent RNase L in chronic fatigue syndrome. J Inferferon Cytokine Res 1997; 17: 377–85.
   PubMed Web of Science ®Google Scholar
• Demitrack MA et al: Evidence for impaired activation of the hypothalamic pituitary adrenal axis in patients with the chronic fatigue syndrome. J Clin Endocri-nol Metab 1991; 73: 1224–34.
   PubMed Web of Science ®Google Scholar
• Sharpe M, Clements A, Hawton K et al: Increased prolactin response to buspi-rone in chronic fatigue syndrome. J Affec Disord 1996; 41: 71–6.
   PubMed Web of Science ®Google Scholar
• Bou-Holaiyah I, Rowe PC et al: The relationship between neurally mediated hypotension and the chronic fatigue syndrome. JAMA 1995; 274: 961–7.
   PubMed Web of Science ®Google Scholar
• Schwartz RB, Komaroff AL, Garada B et al: SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome. AIDS dementia complex, and major unipolar depression. AJR 1994; 162: 943–51.
   Google Scholar
• Abujudeh HH, Levine S, Dayem A: Assessment of regional cerebral perfusion by Tc 99 in HM-PAO Spect in CFS. Radiology 205; 1997: 593.
   PubMedGoogle Scholar
• Abujudeh HH, Levine S, Komar M, Dayem A et al: Comparison between SPECT brain perfusion and F-18 FDG brain uptake in patients with CFS. Eur J Nucl Med 24 1997.
   Google Scholar
• Natelson BH, Johnson SR, Deluca J et al: Reducing heterogeneity in CFS: a comparison with depression and multiple sclerosis. Clin Inf Dis 1995; 21: 1204–10.
   PubMed Web of Science ®Google Scholar
• Johnson S, DeLuca J, Natelson BH: Assessing somatization disorder in CFS. Psychosomatic Med 1996; 58: 50–57.
   PubMed Web of Science ®Google Scholar
• Marcel B, Komaroff AL, Fagioli LR et al: Cognitive deficits in patients with CFS. Biol Psychiatry 1996; 40: 535–41.
   PubMed Web of Science ®Google Scholar
• Terman M, Levine S, Terman J: CFS and seasonal affective disorder: comor-bidity, diagnostic overlap and implications for treatment. Submitted to JAMA.
   Google Scholar
• Malkonson M, Welman Y, Ashash E, Bode Let al: Borna disease in ostriches. Vet Rec 1993 Sep 18; 133(12): 304.
   Web of Science ®Google Scholar
• Takabashi H, Nakaya T, Nakamura Y et al: Higher prevalence of Borna dis-ease virus infections in blood donors living near thoroughbred horse farms. J Med virol 1997 Jul; 52(3): 330–335.
   PubMed Web of Science ®Google Scholar
• Metzler A, Ebrensperger F, Wyler R: Natural borna virus infection in rabbits. Zentralbl Veterinanmed 1978; 25(2): 161.
   PubMedGoogle Scholar
• Kishi M, Nakaya T, Nakamura Y et al: Prevalence of borna disease virus RNA in peripheral mononuclear cells from blood donors. Med Microbiol Immunol 1996; 184: 135–38.
   Web of Science ®Google Scholar
• Rott R, Nerzog S, Fleisher B et al: Detection of serum antibodies to Borna disease virus in patients with psychiatric disorders. Science 1996; 228: 755–56.
   Google Scholar
• Bode L, Ferzt R, Czech G: Borna disease virus infection and affective disor-ders in man. Arch Virol Suppl 1993; 7: 159–67.
   PubMedGoogle Scholar
• Hatalski GG, Lewis AJ, Lipkin WJ: Borna disease virus epidemiology and pathogenesis. Emerging Inf Dis 1996; 3: 129–35.
   Web of Science ®Google Scholar
• Lipkin WI: Borna Disease and mental illness. J California Alliance for the Mentally III 1996; 7: 50–52.
   Google Scholar
• Salvatore M, Morozunov M, Schnemake M, Lilpkin WI and the Bornavirus study group: Borna disease virus in brains of North American and European people with schizophrenia and bipolar disorders. Lancet 1998; 349: 1813–14.
   Google Scholar
• Aunamit W, Ayuthayo PI, Nakuya T, Fujikawa S et al: Unusually high sero-prevalence of Borna disease virus in clade E human immunodeficiency virus type I infected patients with sexually transmitted diseases in Thailand. Clin Diagn Lab Im-munol 1996 Sep; 3(5): 590–93.
   PubMedGoogle Scholar
• Nakaya T, Takahashi H, Nakamura Y et al: Demonstration of borna disease virus RNA in PMNCs derived from Japanese patients with CFS. FEBS letter 1996; 378: 145–9.
   PubMed Web of Science ®Google Scholar
• Stitz L, Bilzer T, Tich JA, Rott R: Pathogenesis of Borna disease. Arch Virol Suppl 1993; 7: 135–51.
   PubMedGoogle Scholar
• Biker T, Plans 0, Lipkin WI, Stitz L: Presence of CD4+ and CD8+ T cells and expression of MHC class I and MHC class II antigen in horses with Borna disease virus induced encephalitis. Brain Pathol 1996; 5: 223.
   Web of Science ®Google Scholar
• Briese T, Hatalski CC, Kliche S, Park YS, Lipkin WI: ELISA for detecting antibodies to Borna disease virus specific proteins. Journal of Clin Microbiology 1995; Feb 33(2): 348–51.
   Google Scholar
• Bode L, Fersyt R, Czech G: Borna disease virus infection and affective disor-ders in man. Arch Virol 1993; (suppl) 7:159–67.
   Google Scholar
• Bode L, Steinbah F, Ludwig H: A novel marker for Borna disease virus infec-tion. Lancet 1994; 343: 297–8.
   PubMed Web of Science ®Google Scholar
• de la Torre JC et al: Detection of Borna disease virus antigen and RNA in hu-man autopsy brain samples from neuropsychiatric patients. virology 1996 Sep 15; 223(2): 272–82.
   PubMed Web of Science ®Google Scholar
• Bode L, Dietrich DF et al: Amantadine and human Borna disease virus in vitro and in vivo in an infected patient with bipolar disorder. Lancet 1998; 349: 178–79.
   Web of Science ®Google Scholar
• Hallensteber W, et al: Borna disease virus is not sensitive to amantadine. Arch Virol 1997; 142: 1–6.
   PubMedGoogle Scholar